Cunningham Chinazo O
Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY, USA.
Top Antivir Med. 2018 Apr;25(4):143-146.
HIV-infected persons are more likely to have chronic pain, receive opioid analgesic treatment, receive higher doses of opioids, and to have substance use disorders and mental illness compared with the general population, putting them at increased risk for opioid use disorder. Management of opioid use in HIV-infected individuals can be complex, and the limited data on opioid treatment in this population are conflicting with regard to its effect on HIV outcomes. Buprenorphine treatment for opioid use disorder improves HIV outcomes and other outcomes. This article summarizes a presentation by Chinazo O. Cunningham, MD, MS at the IAS-USA continuing education program, Improving the Management of HIV Disease, held in Atlanta, Georgia, in March 2017.
与普通人群相比,感染艾滋病毒的人更有可能患有慢性疼痛、接受阿片类镇痛治疗、接受更高剂量的阿片类药物,并且患有物质使用障碍和精神疾病,这使他们患阿片类药物使用障碍的风险增加。艾滋病毒感染者使用阿片类药物的管理可能很复杂,而且关于该人群阿片类药物治疗的有限数据在其对艾滋病毒结果的影响方面存在矛盾。丁丙诺啡治疗阿片类药物使用障碍可改善艾滋病毒结果和其他结果。本文总结了医学博士、理学硕士奇纳佐·O·坎宁安于2017年3月在佐治亚州亚特兰大举行的美国国际艾滋病学会继续教育项目“改善艾滋病毒疾病管理”上的一次演讲。